Navigation Links
Hologic Announces Second Quarter Fiscal 2011 Operating Results
Date:5/2/2011

ettlement charges

-450  Income tax effect of reconciling items

(28,200)

(1)(89,800)

(1)Total Anticipated Non-GAAP Adjustments

$
54,662
$
74,239
Diluted Weighted Average Shares Outstanding264,500

(2)264,500

(2)Explanatory Notes:(1) To reflect an estimated annual effective tax rate of 34% for the third quarter and full year of fiscal 2011 on a non-GAAP basis.

(2) To reflect estimated diluted weighted average shares outstanding of 264,500 for the third quarter and full year of fiscal 2011.Use of Non-GAAP Financial Measures: The Company has presented the following non-GAAP financial measures in this press release: adjusted net income; adjusted EPS; and adjusted EBITDA. The Company defines its non-GAAP adjusted net income to exclude the non-cash amortization of intangible assets, other acquisition-related charges, such as change in contingent consideration, transaction costs, charges associated with the write-off of acquired in-process research and development and the write-up of acquired inventory to fair value, non-cash charges resulting from changes in GAAP, closure and restructuring charges, non-cash loss on exchange of convertible notes, and one-time, nonrecurring, unusual or unanticipated charges, expenses or gains. As set forth in the applicable reconciliation tables above, non-GAAP adjusted net income and non-GAAP adjusted EPS for the periods presented exclude the following items from GAAP net income and EPS: (i) non-cash expenses associated with the Company's acquisitions, including amortization of intangible assets; (ii) non-cash interest expense resulting from the Company's accounting for convertible debt
'/>"/>

SOURCE Hologic, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Hologic to Release Second Quarter Fiscal 2011 Operating Results on Monday, May 2, 2011
2. Hologic, Hospira, Boston Scientific, Allergan to Participate in Leading Medical Device Manufacturing Symposium
3. High Rates of Pathological Complete Response in Patients with Advanced Esophageal Cancer in OPAXIO™ Phase II Study Reported in American Journal of Clinical Oncology
4. Hologic Targets Womens Health Professionals at ECR 2011
5. FDA Approves Hologics Makena™ (Formerly Referred to as Gestiva™) Pharmaceutical
6. Hologic Announces First Quarter Fiscal 2011 Operating Results
7. Hologic Appoints Mark D. Myslinski as Senior Vice President and General Manager of Diagnostics
8. Hologic Acquires Interlace Medical
9. Hologic to Release First Quarter Fiscal 2011 Operating Results on Monday, January 31, 2011
10. Hologic to Participate in Three Investor Conferences
11. Hologic Encourages Health Professionals to Get the Facts About Womens Imaging at RSNA 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... 2015 Global and Chinese ... a professional and in-depth study on the current ... a focus on the Chinese market. Delivery of ... an order is placed. Complete report ... analyzing and profiling 8 major companies and supported ...
(Date:9/4/2015)... , September 4, 2015 According ... Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis) by Procedure ... by Product - Global Forecast to 2020", published by ... USD 2.5 Billion by 2020, growing at a CAGR ... 2020. Browse 139 Tables and 45 ...
(Date:9/4/2015)...  Cumberland Pharmaceuticals (CPIX), today announced that A.J. Kazimi ... on September 10, 2015. DATE: Thursday, September ... http://tinyurl.com/sep10pre This will be a ... ask the company questions in real-time - both in ... trade booth." If attendees are not able to join ...
Breaking Medicine Technology:Surgical Gown Market 2020 Forecasts With a Focus on China 2Surgical Gown Market 2020 Forecasts With a Focus on China 3Surgical Gown Market 2020 Forecasts With a Focus on China 4Apheresis Market Worth 2.5 Billion USD by 2020 2Apheresis Market Worth 2.5 Billion USD by 2020 3Apheresis Market Worth 2.5 Billion USD by 2020 4Apheresis Market Worth 2.5 Billion USD by 2020 5Cumberland Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com September 10 2
... this very moment, FIRMOO is being heatedly discussed by more ... FIRMOO are being delivered to various countries of the world. ... eyeglasses wearers? In this brand new year of 2012, FIRMOO, ... giving away thousands of free eyeglasses every day and is ...
... ViroPharma Incorporated (NASDAQ: VPHM ) and ... announced the presentation of positive data from ViroPharma,s ... inhibitor [human]) in combination with Halozyme,s Enhanze™ technology, ... human hyaluronidase enzyme (rHuPH20), in patients with hereditary ...
Cached Medicine Technology:Free Glasses from FIRMOO - Welcome to Your Glasses Kingdom 2Free Glasses from FIRMOO - Welcome to Your Glasses Kingdom 3ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20) 2ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20) 3ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20) 4ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20) 5ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20) 6ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20) 7ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20) 8
(Date:9/4/2015)... ... ... access to a doctor can sometimes be a challenge for a variety of reasons. ... affects hospitals’ abilities to provide quality service to those with serious needs, increases insurance ... has recently presented itself, the new telemedicine platform and app, DocChat . ...
(Date:9/4/2015)... , ... September 04, 2015 , ... Lalonde Gordon ran ... and followed up with victory in the men’s 400 meters final, with an impressive ... and Field Championships in San Jose, Costa Rica in August 2015. The 44.64 time ...
(Date:9/4/2015)... ... 2015 , ... Compliance officers deal with many high-risk issues, ... self-referral law. “Stark Law DOs and DON’Ts: Best Practices for Your Physician ... will detail which deals are attracting the most government scrutiny and what are ...
(Date:9/4/2015)... Charlotte, NC (PRWEB) , ... September 04, 2015 ... ... water filtration products, has a Labor Day offer that cannot be passed up. ... to stock up on necessary air and water filtration product replacements. Take advantage ...
(Date:9/4/2015)... ... , ... Friday night, Chicago lovebirds Jenny McCarthy and Donnie Wahlberg celebrated their ... supporting families affected by autism, raising nearly $250,000. , 150 guests, including event ... Oscar Swan Inn to support the cause. , McCarthy tugged the heartstrings of ...
Breaking Medicine News(10 mins):Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2Health News:Jenny McCarthy & Donnie Wahlberg Help Raise Over $200,000 For Generation Rescue’s ‘Night Of Hope’ Chicago Charity Event 2
... SHENYANG, China, May 19 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq:, ... China-based biotechnology company,focused on researching, developing, manufacturing and marketing,biopharmaceutical ... quarter ended March 31, 2009. , , ... -- Total net revenues increased 23.7% over the first ...
... but spared healthy cells , , TUESDAY, May ... cells, armed with a cancer-killing protein, have proven ... sparing healthy cells, new research has found. , ... lung, squamous, breast and cervical cancer cells in ...
... the HIMSS Patient Safety, Quality and Outcomes Committee and ... Steering CommitteeANN ARBOR, Mich., May 19 Dr. Louis ... and Science business of Thomson Reuters, was recently named ... Committee and vice chair of the eHealth Initiative Policy ...
... 19 CSX Corporation Chairman and Chief Executive Officer ... in recognition of his ongoing support of Wounded Warrior ... last year, helped create the nation,s first Training and ... services to complete their transition to civilian lives. Ward,s ...
... 19 Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) announces the following webcast:, ... in, conjunction with ... corporate update will be presented by Stanley T. Crooke, ... and Chief Executive Officer of Isis., When: Tuesday, June ...
... ARBOR, Mich., May 19 Three Ann Arbor-based companies ... from the Michigan Economic Development Corp. Velesco Pharmaceutical ... today for MEGA tax credits from the State of ... strong entrepreneurial culture supported in the Ann Arbor region ...
Cached Medicine News:Health News:3SBio Inc. Announces Unaudited First Quarter 2009 Results 2Health News:3SBio Inc. Announces Unaudited First Quarter 2009 Results 3Health News:3SBio Inc. Announces Unaudited First Quarter 2009 Results 4Health News:3SBio Inc. Announces Unaudited First Quarter 2009 Results 5Health News:3SBio Inc. Announces Unaudited First Quarter 2009 Results 6Health News:3SBio Inc. Announces Unaudited First Quarter 2009 Results 7Health News:3SBio Inc. Announces Unaudited First Quarter 2009 Results 8Health News:3SBio Inc. Announces Unaudited First Quarter 2009 Results 9Health News:3SBio Inc. Announces Unaudited First Quarter 2009 Results 10Health News:3SBio Inc. Announces Unaudited First Quarter 2009 Results 11Health News:3SBio Inc. Announces Unaudited First Quarter 2009 Results 12Health News:3SBio Inc. Announces Unaudited First Quarter 2009 Results 13Health News:3SBio Inc. Announces Unaudited First Quarter 2009 Results 14Health News:3SBio Inc. Announces Unaudited First Quarter 2009 Results 15Health News:3SBio Inc. Announces Unaudited First Quarter 2009 Results 16Health News:3SBio Inc. Announces Unaudited First Quarter 2009 Results 17Health News:Stem Cell Study Offers Hope for Targeting Tumors 2Health News:Thomson Reuters Medical Director Named to Healthcare Industry Leadership Roles 2Health News:Thomson Reuters Medical Director Named to Healthcare Industry Leadership Roles 3Health News:Michael Ward Cited for Support of Wounded Warrior Project 2Health News:Webcast Alert: Isis Pharmaceuticals To Provide General Corporate Update in Conjunction with 2009 Annual Meeting of Stockholders 2Health News:Three Michigan Companies Expand in Ann Arbor with MEDC Support 2
...
The Select 3D Arterial cannulae from Medtronic features a tip configuration which diffuses the flow through multiple outlets. This unique tip design provides reduced velocity with one central and thr...
The Medtronic EOPA CAP® arterial cannula provides a simple solution to obtaining accurate arterial pressure readings....
Intermittent catheter...
Medicine Products: